IMP-15-Producing Pseudomonas aeruginosa Strain Isolated in a U.S. Medical Center: a Recent Arrival from Mexico
- 1 June 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6), 2289-2290
- https://doi.org/10.1128/aac.00299-08
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- bla VIM-2 and bla VIM-7 Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC ProgramJournal of Clinical Microbiology, 2007
- First Occurrence of a Pseudomonas aeruginosa Isolate in the United States Producing an IMP Metallo-β-Lactamase, IMP-18Antimicrobial Agents and Chemotherapy, 2006
- An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004Diagnostic Microbiology and Infectious Disease, 2005
- First Nosocomial Outbreak of Pseudomonas aeruginosa Producing an Integron-Borne Metallo-β-Lactamase (VIM-2) in the United StatesAntimicrobial Agents and Chemotherapy, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- bla VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United StatesAntimicrobial Agents and Chemotherapy, 2004